Evidence map›Paper›PMID 34281170›Full record

ArticleInternational journal of molecular sciences2021

In Silico Target Prediction of Overexpressed microRNAs from LPS-Challenged Zebrafish (

Geonildo R Disner, Maria A P Falcão, Carla Lima, Monica Lopes-Ferreira

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Dihydroartemisinin ameliorates chronic nonbacterial prostatitis and epithelial cellular inflammation by blocking the E2F7/HIF1α pathway.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Article
  4. Frontiers in immunology · 2022
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Geonildo R DisnerImmunoregulation Unit of the Laboratory of Applied Toxinology (CeTICS/FAPESP), Butantan Institute, São Paulo 05503-900, Brazil.ORCID 0000-0002-4561-1361
Maria A P FalcãoImmunoregulation Unit of the Laboratory of Applied Toxinology (CeTICS/FAPESP), Butantan Institute, São Paulo 05503-900, Brazil.ORCID 0000-0003-3097-6285
Carla LimaImmunoregulation Unit of the Laboratory of Applied Toxinology (CeTICS/FAPESP), Butantan Institute, São Paulo 05503-900, Brazil.ORCID 0000-0002-8161-966X
Monica Lopes-FerreiraImmunoregulation Unit of the Laboratory of Applied Toxinology (CeTICS/FAPESP), Butantan Institute, São Paulo 05503-900, Brazil.
Instituto Butantan · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 305414/2019-4Fundação de Amparo à Pesquisa do Estado de São Paulo #2013/07467-1; #2019/27677-7
6 · The paper itself

Abstract

miRNAs regulate gene expression post-transcriptionally in various processes, e.g., immunity, development, and diseases. Since their experimental analysis is complex, in silico target prediction is important for directing investigations.

Indexed as

AnimalsAnti-Inflammatory AgentsComputational BiologyComputer SimulationDNA-Binding ProteinsFish VenomsGene ExpressionGene OntologyImmunity, InnateLipopolysaccharidesMicroRNAsPeptidesTranscription FactorsTranscriptomeZebrafishAnti-Inflammatory AgentsDNA-Binding ProteinsFish VenomsLipopolysaccharidesMicroRNAsMIRN122 microRNA, zebrafishMIRN21 microRNA, zebrafishMirn26 microRNA, zebrafishPeptidesTranscription FactorsbioinformaticsepigeneticinflammationmiRNAsontologypreclinical toxicological studiesTnP

Identifiers

PMID34281170
PMCPMC8268205
OpenAlexW3181195221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.